Acta Diabetologica

, Volume 48, Issue 3, pp 183–189 | Cite as

Effects of exercise on inflammation markers in type 2 diabetic subjects

Review Article

Abstract

Endothelial dysfunction and plasma markers of inflammation are significantly increased in type 2 diabetics. Several proinflammatory cytokines, acute-phase proteins, and cell adhesion molecules, such as C-reactive protein (CRP), interleukines (IL), and tumor necrosis factor alpha (TNF-α), seem to play a role in the low-grade systemic inflammation observed in these subjects. Lifestyle changes are necessary to prevent atherosclerosis and cardiovascular events. Physical exercise is known to reduce markers of inflammation by decreasing adipocytokine production and cytokine release from skeletal muscles, endothelial cells, and immune system and also improving antioxidant status. In type 2 diabetics, aerobic and resistance training have different effects on cytokine levels, and the differences in the modalities of exercise (type, duration, and intensity) and especially in the examined population could produce different results. Recent research showed that combined exercise has greater anti-inflammatory effects than aerobic or resistance exercise alone causing a deepest decrease in CRP, IL-6, IL-1β, TNF-α, leptin, and resistin and a higher increase in anti-inflammatory cytokines such as IL-4, IL-10, and adiponectin.

Keywords

Type 2 diabetes mellitus Aerobic exercise Resistance exercise Inflammation 

References

  1. 1.
    Prestes J, Shiguemoto G, Botero JP, Frollini A, Dias R, Leite R, Pereira G, Magosso R, Baldissera V, Cavaglieri C, Perez S (2009) Effects of resistance training on resistin, leptin, cytokines, and muscle force in elderly post-menopausal women. J Sports Sci 27:1607–1615PubMedCrossRefGoogle Scholar
  2. 2.
    Garcia C, Feve B, Ferré P, Halimi S, Baizri H, Bordier L, Guiu G, Dupuy O, Bauduceau B, Mayaudon H (2010) Diabetes and inflammation: fundamental aspects and clinical implications. Diabetes Metab 36:327–338PubMedCrossRefGoogle Scholar
  3. 3.
    Ray A, Huisman MV, Tamsa JT (2009) The role of inflammation on atherosclerosis, intermediate and clinical cardiovascular endpoints in type 2 diabetes mellitus. Eur J Intern Med 20:253–260PubMedCrossRefGoogle Scholar
  4. 4.
    Thomsen SB, Rathcke CN, Zerahn B, Vestergaard H (2010) Increased levels of the calcification marker matrix Gla protein and the inflammatory markers YKL-40 and CRP in patients with type 2 diabetes and ischemic heart disease. Cardiovasc Diab 9:86CrossRefGoogle Scholar
  5. 5.
    Kajitani N, Shikata K, Nakamura A, Nakatou T, Hiramatsu M, Makino H (2010) Microinflammation is a common risk factor for progression of nephropathy and atherosclerosis in Japanese type 2 diabetes mellitus. Diab Res Clin Pract 88:171–176CrossRefGoogle Scholar
  6. 6.
    Balducci S, Zanuso S, Nicolucci A, Fernando F, Cavallo S, Cardelli P, Fallucca S, Alessi E, Letizia C, Jimenez A, Fallucca F, Pugliese G (2010) Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss. Nutr Metab Cardiovasc Dis 20:608–617PubMedCrossRefGoogle Scholar
  7. 7.
    Pearson TA, Mensah GA, Alexabder RW, Anderson JL, Cannon RO 3rd, Criqui M et al (2003) AHA/CDC scientific statement. Markers of inflammation and cardiovascular disease. Application to clinical and public health practice. A statement for healthcare professionals from the Centers for Disease Control and prevention and the American Heart Association. Circulation 107:499–511PubMedCrossRefGoogle Scholar
  8. 8.
    Swellam M, Sayed Mahmoud M, Abdel-Fatah Ali A (2009) Clinical implications of adiponectin and inflammatory biomarkers in type 2 diabetes mellitus. Dis Markers 27:269–278PubMedGoogle Scholar
  9. 9.
    Sallam N, Khazaei M, Laher I (2010) Effect of moderate-intensity exercise on plasma C-reactive protein and aortic endothelial function in type 2 diabetic mice. Mediators Inflamm. Epub 2010 Aug 2Google Scholar
  10. 10.
    Rytter E, Vessby B, Asgard R, Johansson C, Sjoidin A, Abramson-Zetterberg L, Moller L, Basu S (2009) Glycaemic status in relation to oxidative stress and inflammation in well controlled type 2 diabetes subjects. Br J Nutr 101:1423–1426PubMedCrossRefGoogle Scholar
  11. 11.
    Hansen D, Dendale P, Beelen M, Jonkers RAM, Mullens A, Corluy L, Meeusen R, Van Loon LJC (2010) Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients. Eur J Appl Physiol 109:397–404PubMedCrossRefGoogle Scholar
  12. 12.
    Sam S, Haffner S, Davidson MH, D’Agostino RB, Feinstein S, Kondos G, Perez A, Mazzone T (2009) Relation of abdominal fat depots to systemic markers of inflammation in type 2 diabetes. Diabetes Care 32:932–937PubMedCrossRefGoogle Scholar
  13. 13.
    Nayak S, Soon SQ, Kunjal R, Ramadoo R, Baptiste O, Persad J, Temull V, Diptee L, Balgobin S (2009) Relationship between adiponectin, inflammatory markers and obesity in type 2 diabetic and non diabetic Trinidadians. Arch Physiol Biochem 115:28–33PubMedCrossRefGoogle Scholar
  14. 14.
    Mahajan A, Tabassum R, Chavali S, Dwivedi OP, Bharadwaj M, Tandon N, Bharadwaj D (2009) High-sensitivity C-reactive protein levels and type 2 diabetes in urban North Indians. J Clin Endocrinol Metab 94:2123–2127PubMedCrossRefGoogle Scholar
  15. 15.
    Aronson D, Sheikh-Ahmad M, Avizohar O, Kerner A, Sella R, Bartha P, Markiewicz W, Levy I, Brook GJ (2004) C-reactive protein is inversely related to physical fitness in middle-aged subjects. Atherosclerosis 176:173–179PubMedCrossRefGoogle Scholar
  16. 16.
    Aronson D, Sella R, Sheikh-Ahmad M, Kerner A, Avizohar O, Rispler S, Bartha P, Markiewicz W, Levy I, Brook GJ (2004) The association between cardiorespiratory fitness and C-reactive protein in subjects with the metabolic syndrome. J Am Coll Cardiol 44:2003–2007PubMedCrossRefGoogle Scholar
  17. 17.
    Goldhammer E, Tanchillevitch A, Maor I, Beniamini Y, Rosenschein U, Sagiv M (2005) Exercise training modulates cytokines activity in coronaryhearth disease patients. Int J Cardiol 100:93–99PubMedCrossRefGoogle Scholar
  18. 18.
    American Diabetes Association (2011) Standards for medical care in diabetes. Diabetes Care 34(S1):S11–S61CrossRefGoogle Scholar
  19. 19.
    Zanuso S, Jimenez A, Pugliese G, Corigliano G, Balducci S (2010) Exercise for the management of type 2 diabetes: a review of evidence. Acta Diabetol 47:15–22PubMedCrossRefGoogle Scholar
  20. 20.
    Ribeiro F, Alves AJ, Duarte JA, Oliverira J (2010) Is exercise training an effective therapy targeting endothelial dysfunction and vascular wall inflammation? Int J Cardiol 141:214–221PubMedCrossRefGoogle Scholar
  21. 21.
    Calle MC, Fernandez ML (2010) Effects of resistance training on the inflammatory response. Nutr Res Pract 4:259–269PubMedCrossRefGoogle Scholar
  22. 22.
    Petersen AM, Pedersen BK (2006) The role of IL-6 in mediating the anti-inflammatory effects of exercise. J Physiol Pharmacol 57(S10):43–51PubMedGoogle Scholar
  23. 23.
    Drenth JP, Van Uum SH, Van Deuren M, Pesman GJ, Van der Ven-Jongekrijg J, Van der Meer JW (2005) Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-alpha and IL-1 beta production. J Appl Physiol 79:1497–1503Google Scholar
  24. 24.
    Stewart LK, Flynn MG, Campbell WW, Craig BA, Robinson JP, Timmermann KL, McFarlin BK, Coen PM, Talbert E (2007) The influence of exercise training on inflammatory cytokines and C-reactive protein. Med Sci Sports Exerc 39:1714–1719PubMedCrossRefGoogle Scholar
  25. 25.
    Perrier S, Darakhshan F, Hajduch E (2006) IL-1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde? FEBS Lett 580:6289–6294PubMedCrossRefGoogle Scholar
  26. 26.
    Pedersen BK, Febbraio MA (2007) Point: interleukin-6 does have a beneficial role in insulin sensitivity and glucose homeostasis. J Appl Physiol 102:804–806Google Scholar
  27. 27.
    Prokopchuk O, Liu Y, Wang L, Wirth K, Schimdtbleicher D, Steinacker JM (2007) Skeletal muscle IL-4, IL-4Ralpha, IL13 and IL-13Ralpha1 expression and response to strength training. Exerc Immunol Rev 13:67–75PubMedGoogle Scholar
  28. 28.
    Gordon PL, Vannier E, Hamada K, Layne J, Hurley BF, Roubenoff R, Castaneda-Sceppa C (2006) Resistance training alters cytokine gene expression in skeletal muscle of adults with type 2 diabetes. Int J Immunopatol Pharmacol 19:739–749Google Scholar
  29. 29.
    Tantiwong P, Shanmugasundaram K, Monroy A, Ghosh S, Li M, DeFronzo RA, Cersosimo E, Sriwijitkamol A, Mohan S, Musi N (2010) NF-κB activity in muscle from obese and type 2 diabetic subjects under basal and exercise-stimulated conditions. Am J Physiol Endocrinol Metab 299(5):E794–E801. Epub 2010 Aug 24Google Scholar
  30. 30.
    Santos MJ, Fonseca JE (2009) Metabolic syndrome, inflammation and atherosclerosis–the role of adipokines in health and in systemic inflammatory rheumatic disease. Acta Reumatol Port 34:590–598PubMedGoogle Scholar
  31. 31.
    Wang Z, Nakayama T (2010) Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm 535918. Epub 2010 Aug 5Google Scholar
  32. 32.
    Lim S, Choi SH, Jeong IK, Kim JH, Moon MK, Park KS, Lee HK, Kim YB, Jang HK (2008) Insulin-sensitizing effects of exercise on adiponectin and retinol-binding protein-4 concentrations in young and middle-aged women. J Clin Endocrinol Metab 93:2263–2268PubMedCrossRefGoogle Scholar
  33. 33.
    Ku YH, Han KA, Ahn H, Kwon H, Koo BK, Kim HC, Min KW (2010) Resistance exercise did not alter intramuscular adipose tissue but reduced retinol-binding protein-4 concentration in individuals with type 2 diabetes mellitus. J Int Med Res 38:782–791PubMedGoogle Scholar
  34. 34.
    Ahmadizad S, Haghighi AH, Hamedinia MR (2007) Effects of resistance versus endurance training on serum adiponectin and insulin resistance index. Eur J Endocrinol 157:625–631PubMedCrossRefGoogle Scholar
  35. 35.
    Ibanez J, Izquierdo M, Martinez-Labari C, Ortega F, Grijalba A, Forga L, Idoate F, Garcia-Unciti M, Fernandez-Real JM, Gorostiaga EM (2010) Resistance training improves cardiovascular risk factors in obese women despite a significant decrease in serum adiponectin levels. Obesity 18:535–541PubMedCrossRefGoogle Scholar
  36. 36.
    Bloem CJ, Chang AM (2008) Short-term exercise improves cell function and insulin resistance in older people with impaired glucose tolerance. J Clin Endocrinol Metab 93:387–392PubMedCrossRefGoogle Scholar
  37. 37.
    Praet SFE, Jonkers RAM, Schep G, Stehouwer CDA, Kuipers H, Keizer HA, Van Loon LJ (2008) Long-standing, insulin-treated type 2 diabetes patients with complications respond well to short-term resistance and interval exercise training. Eur J Endocrinol 158:163–172PubMedCrossRefGoogle Scholar
  38. 38.
    Praet SFE, Van Loon LJ (2009) Exercise therapy in type 2 diabetes. Acta Diabetol 46:263–278PubMedCrossRefGoogle Scholar
  39. 39.
    Brooks N, Layne JE, Gordon PL, Roubenoff R, Nelson ME, Castaneda-Sceppa C (2007) Strength training improves muscle quality and insulin sensitivity in Hispanic older adults with type 2 diabetes. Int J Med Sci 4:19–27Google Scholar
  40. 40.
    Simpson KA, Singh MA (2008) Effects of exercise on adiponectin: a systematic review. Obesity 16:241–256PubMedCrossRefGoogle Scholar
  41. 41.
    Andersson J, Jansson JH, Hellsten G, Nilsson TK, Hallmans G, Boman K (2010) Effects of heavy endurance physical exercise on inflammatory markers in non-athletes. Atherosclerosis 209:601–605PubMedCrossRefGoogle Scholar
  42. 42.
    Nicklas BJ, Ambrosius W, Messier SP, Miller GD, Penninx BWJH, Loeser RF, Palla S, Bleecker E, Pahor M (2004) Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial. Am J Clin Nutr 79:544–551PubMedGoogle Scholar
  43. 43.
    You T, Nicklas BJ (2006) Chroonic inflammation: role of adipose tissue and modulation by weight loss. Curr Diabetes Rev 2:29–37PubMedCrossRefGoogle Scholar
  44. 44.
    Sixt S, Beer S, Bluher M, Korff N, Peschel T, Sonnabend M, Teupser D, Thiery J, Adams V, Schuler G, Niebauer J (2010) Long- but not short-term multifactorial intervention with focus on exercise training improves coronary endothelial dysfunction in diabetes mellitus type 2 and coronary artery disease. Eur Heart J 31:112–119PubMedCrossRefGoogle Scholar
  45. 45.
    Kadoglou NP, Iliadis F, Angelopoulou N, Perrea D, Ampatzidis G, Liapis CD, Alevizos M (2007) The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus. Eur J Cardiovasc Prev Rehabil 14:837–843Google Scholar
  46. 46.
    Di Penta JM, Green-Johnson JM, Murphy RJL (2007) Type 2 diabetes mellitus, resistance training, and innate immunity: is there a common link? Appl Physiol Nutr Metab 32:1025–1035CrossRefGoogle Scholar
  47. 47.
    Li ZZ, Liu JB, Jiao L, Chen L (2009) Intensive therapy for diabetes through influence on innate immune system. Med Hypotheses 72:675–676PubMedCrossRefGoogle Scholar
  48. 48.
    Troseid M, Lappegard KT, Claudi T, Damas JK, Morkrid L, Brendberg R, Mollness TE (2004) Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome. Eur Hearth J 25:349–355CrossRefGoogle Scholar
  49. 49.
    Troseid M, Lappegard KT, Mollness TE, Arnesen H, Seljeflot I (2009) The effect of exercise on serum levels of IL-18 and components of the metabolic syndrome. Metab Syndr Relat Disord 7:579–584PubMedCrossRefGoogle Scholar
  50. 50.
    Oberbach A, Tonjes A, Kloting N, Fasshauer M, Kratzsch J, Busse MW, Paschke R, Stomwoll M, Bluher M (2006) Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance. Eur J Endocrinol 154:577–585PubMedCrossRefGoogle Scholar
  51. 51.
    Herder C, Peltonen M, Koenig W, Suftels K, Lindstrom J, Martin S, Ilanne-Parikka P, Eriksson JG, Aunola S, Keinanen-Kiukaanniemi S, Valle TT, Uusitopa M, Kolb H, Tuomilehto J (2009) Anti-inflammatory effect of lifestyle changes in the Finnish Diabetes Prevention Study. Diabetologia 52:433–442PubMedCrossRefGoogle Scholar
  52. 52.
    Zoppini G, Targher G, Zamboni C, Venturi C, Cacciatori V, Moghetti P, Muggeo M (2006) Effects of moderate-intensity exercise training on plasma biomarkers of inflammation and endothelial dysfunction in older patients with type 2 diabetes. Nutr Metab Cardiovasc Dis 16:543–549PubMedCrossRefGoogle Scholar
  53. 53.
    De Salles BF, Simao R, Fleck SJ, Dias I, Kraemer-Aguiar LG, Bouskela E (2010) Effects of resistance training on cytokines. Int J Sports Med 31:441–450PubMedCrossRefGoogle Scholar
  54. 54.
    Flack KD, Davy KP, Hulver MW, Winett RA, Frisard MI, Davy BM (2010) Aging, resistance training and diabetes prevention. J Aging Res 2011:127315Google Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  1. 1.Dipartimento di Medicina Interna, Malattie Cardiovascolari e NefrourologicheUniversità degli Studi di PalermoPalermoItaly

Personalised recommendations